These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1759235)
21. Treatment of hypertension with dihydropyridine calcium antagonists and aspirin. Tison P; Ulicna L; Jakubovska Z; Oravcova J; Fetkovska N Blood Press Suppl; 1994; 1():57-60. PubMed ID: 8205303 [TBL] [Abstract][Full Text] [Related]
22. Does aldosterone-to-renin ratio predict the antihypertensive effect of the aldosterone antagonist spironolactone? Mahmud A; Mahgoub M; Hall M; Feely J Am J Hypertens; 2005 Dec; 18(12 Pt 1):1631-5. PubMed ID: 16364838 [TBL] [Abstract][Full Text] [Related]
23. Long-term effectiveness of BAY e 5009-nitrendipine in the treatment of mild and moderate arterial hypertension. Esper RJ; Esper RC; Baglivo HP; Castro JM; Rohwedder RW; Menna J J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1096-9. PubMed ID: 6085374 [TBL] [Abstract][Full Text] [Related]
24. Calcium antagonists as a new treatment modality in hypertension. Laragh JH Angiology; 1988 Jan; 39(1 Pt 2):100-5. PubMed ID: 3277491 [TBL] [Abstract][Full Text] [Related]
25. [Hypotensive properties of nisoldipine. Comparative study in essential, renal and renovascular hypertension]. Wambach G; Breuer G; Kaufmann W Arzneimittelforschung; 1984; 34(5):620-3. PubMed ID: 6540581 [TBL] [Abstract][Full Text] [Related]
26. [Antihypertensive effect of nitrendipine, nifedipine and acebutolol and their combination on resting and exercise blood pressure in hypertensive patients]. Franz IW; Wiewel D Z Kardiol; 1985 Feb; 74(2):111-6. PubMed ID: 3158125 [TBL] [Abstract][Full Text] [Related]
27. [Depin-E in the treatment of hypertensive crises in patients with essential and secondary arterial hypertension]. Breskina TN; Demidova AB; Konoshenok GV; Chinilina IV Ter Arkh; 1990; 62(9):64-7. PubMed ID: 2281409 [TBL] [Abstract][Full Text] [Related]
28. High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension. Andreadis EA; Tsourous GI; Marakomichelakis GE; Katsanou PM; Fotia ME; Vassilopoulos CV; Diamantopoulos EJ J Hum Hypertens; 2005 Jun; 19(6):491-6. PubMed ID: 15759025 [TBL] [Abstract][Full Text] [Related]
29. Antihypertensive effects of intravenous administration of benidipine hydrochloride and some other calcium antagonists in conscious, spontaneously hypertensive rats. Karasawa A; Kubo K; Oka T; Nakamizo N Arzneimittelforschung; 1988 Nov; 38(11A):1691-4. PubMed ID: 3219141 [TBL] [Abstract][Full Text] [Related]
30. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367 [TBL] [Abstract][Full Text] [Related]
31. Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension. Kazda S; Garthoff B; Knorr A Fed Proc; 1983 Feb; 42(2):196-200. PubMed ID: 6822291 [TBL] [Abstract][Full Text] [Related]
32. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension. Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364 [TBL] [Abstract][Full Text] [Related]
33. Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension. Cerasola G; Cottone S; Mangano MT; D'Ignoto G; Pinto A; Carone MB Clin Ther; 1988; 10(6):694-703. PubMed ID: 2975530 [TBL] [Abstract][Full Text] [Related]
34. Effects of a calcium antagonist on the pituitary-adrenal axis. Rocco S; Mantero F; Boscaro M Horm Metab Res; 1993 Feb; 25(2):114-6. PubMed ID: 8384597 [TBL] [Abstract][Full Text] [Related]
35. Erythrocyte sodium cannot predict hypotensive effects of calcium channel blockers. Oshima T; Matsuura H; Ozono R; Ishida-Kainouchi M; Ishida T; Ishibashi K; Watanabe M; Okura Y; Kanbe M; Kajiyama G Nihon Jinzo Gakkai Shi; 1993 Nov; 35(11):1227-31. PubMed ID: 8139134 [TBL] [Abstract][Full Text] [Related]
36. [The dynamics of the concentration of atrial natriuretic factor depending on changes in the arterial pressure level in patients with arterial hypertension]. Tomashets EA; Mazur NA; Masenko VP Ter Arkh; 1992; 64(4):12-5. PubMed ID: 1440297 [TBL] [Abstract][Full Text] [Related]
37. [Relations between hypotensive effect and modifications of volemia and plasma renin activity in patients with essential hypertension treated using spironolactone]. Pessina AC; Corgnati A; Palù CD Minerva Med; 1977 Feb; 68(8):509-14. PubMed ID: 846681 [TBL] [Abstract][Full Text] [Related]
38. Acute and short-term effects of new calcium antagonist in hypertension. Burris JF; Notargiacomo AV; Papademetriou V; Freis ED Hypertension; 1982; 4(3 Pt 2):32-5. PubMed ID: 7068206 [TBL] [Abstract][Full Text] [Related]
39. [The efficacy of nitrendipine in patients with stable arterial hypertension. The data from a cooperative study in the USSR. The Working Group for the Cooperative Study of Nitrendipine]. Metelitsa VI; Ostrovskaia TP Ter Arkh; 1992; 64(4):39-43. PubMed ID: 1440306 [TBL] [Abstract][Full Text] [Related]
40. Nitrendipine, a calcium-entry blocker. Renal and humoral effects in human arterial hypertension. Pedrinelli R; Fouad FM; Tarazi RC; Bravo EL; Textor SC Arch Intern Med; 1986 Jan; 146(1):62-5. PubMed ID: 2935106 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]